Institute for Virology, Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University of Mainz, Mainz, Germany.
TRON - Translational Oncology, Medical Center of the Johannes Gutenberg-University Mainz gGmbH, Mainz, Germany.
Front Cell Infect Microbiol. 2020 Aug 26;10:454. doi: 10.3389/fcimb.2020.00454. eCollection 2020.
Murine cytomegalovirus (mCMV) codes for MHC class-I trafficking modulators m04/gp34, m06/gp48, and m152/gp40. By interacting with the MHC class-Iα chain, these proteins disconnect peptide-loaded MHC class-I (pMHC-I) complexes from the constitutive vesicular flow to the cell surface. Based on the assumption that all three inhibit antigen presentation, and thus the recognition of infected cells by CD8 T cells, they were referred to as "immunoevasins." Improved antigen presentation mediated by m04 in the presence of m152 after infection with deletion mutant mCMV-Δm06, compared to mCMV-Δm04m06 expressing only m152, led us to propose renaming these molecules "viral regulators of antigen presentation" (vRAP) to account for both negative and positive functions. In accordance with a positive function, m04-pMHC-I complexes were found to be displayed on the cell surface, where they are primarily known as ligands for Ly49 family natural killer (NK) cell receptors. Besides the established role of m04 in NK cell silencing or activation, an anti-immunoevasive function by activation of CD8 T cells is conceivable, because the binding site of m04 to MHC class-Iα appears not to mask the peptide binding site for T-cell receptor recognition. However, functional evidence was based on mCMV-Δm06, a virus of recently doubted authenticity. Here we show that mCMV-Δm06 actually represents a mixture of an authentic deletion mutant and a mutant with an accidental additional deletion of a genome region encompassing also gene . Reanalysis of previously published experiments for the authentic mutant in the mixture confirms the previously concluded positive vRAP function of m04.
鼠巨细胞病毒 (mCMV) 编码 MHC Ⅰ类分子转运调节剂 m04/gp34、m06/gp48 和 m152/gp40。这些蛋白通过与 MHC Ⅰ类α链相互作用,将负载肽的 MHC Ⅰ类 (pMHC-Ⅰ) 复合物从组成型囊泡流中分离出来,使其无法到达细胞表面。基于所有三种蛋白都能抑制抗原呈递,从而抑制 CD8 T 细胞识别感染细胞的假设,它们被称为“免疫逃逸蛋白”。感染缺失突变体 mCMV-Δm06 后,m04 介导的抗原呈递比仅表达 m152 的 mCMV-Δm04m06 有所改善,这促使我们提出重新命名这些分子为“病毒调控抗原呈递”(vRAP),以解释其负向和正向功能。与负向功能一致,m04-pMHC-Ⅰ复合物被发现呈现在细胞表面,在那里它们主要作为 Ly49 家族自然杀伤 (NK) 细胞受体的配体。除了 m04 在 NK 细胞沉默或激活中的既定作用外,由于 m04 与 MHC Ⅰ类α的结合位点似乎不会掩盖 TCR 识别的肽结合位点,因此可以设想其通过激活 CD8 T 细胞发挥抗免疫逃逸功能。然而,功能证据基于 mCMV-Δm06,这是一种最近被怀疑真实性的病毒。在这里,我们表明 mCMV-Δm06 实际上代表了一种真实缺失突变体和一种意外额外缺失包含基因的基因组区域的突变体的混合物。对混合物中真实突变体的先前发表实验的重新分析证实了 m04 先前得出的正向 vRAP 功能。